Literature DB >> 16720550

APOBEC family proteins: novel antiviral innate immunity.

Akifumi Takaori-Kondo1.   

Abstract

APOBEC3G has been identified as an anti-human immunodeficiency virus type 1 (HIV-1) host factor that belongs to the APOBEC superfamily of cytidine deaminases. It deaminates cytidine to uridine in nascent minus-strand viral DNA, inducing G-to-A hypermutation in the plus-strand DNA of HIV-1. The accumulating evidence demonstrates that APOBEC family proteins also have an antiviral activity against a wide variety of viruses, including not only retroviruses but also other types of viruses, and that each virus seems to have its own strategy for escaping from APOBEC proteins. These results suggest that the APOBEC3 family plays an important role in antiviral host defense as an innate immunity. Recent progress in research on APOBEC family proteins is reviewed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720550     DOI: 10.1532/IJH97.05187

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  47 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  Comment on "Inhibition of hepatitis B virus replication by APOBEC3G".

Authors:  Christine Rösler; Josef Köck; Michael H Malim; Hubert E Blum; Fritz von Weizsäcker
Journal:  Science       Date:  2004-09-03       Impact factor: 47.728

3.  Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors.

Authors:  Rebecca A Russell; Heather L Wiegand; Michael D Moore; Alexandra Schäfer; Myra O McClure; Bryan R Cullen
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  APOBEC3G hypermutates genomic DNA and inhibits Ty1 retrotransposition in yeast.

Authors:  April J Schumacher; Dwight V Nissley; Reuben S Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-06       Impact factor: 11.205

5.  Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases.

Authors:  James A Dutko; Alexandra Schäfer; Alison E Kenny; Bryan R Cullen; M Joan Curcio
Journal:  Curr Biol       Date:  2005-04-12       Impact factor: 10.834

6.  APOBEC3G targets specific virus species.

Authors:  Masayuki Kobayashi; Akifumi Takaori-Kondo; Keisuke Shindo; Aierken Abudu; Keiko Fukunaga; Takashi Uchiyama
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif.

Authors:  Roberto Mariani; Darlene Chen; Bärbel Schröfelbauer; Francisco Navarro; Renate König; Brooke Bollman; Carsten Münk; Henrietta Nymark-McMahon; Nathaniel R Landau
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

8.  APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.

Authors:  Qin Yu; Darlene Chen; Renate König; Roberto Mariani; Derya Unutmaz; Nathaniel R Landau
Journal:  J Biol Chem       Date:  2004-10-04       Impact factor: 5.157

9.  Molecular cloning of an apolipoprotein B messenger RNA editing protein.

Authors:  B Teng; C F Burant; N O Davidson
Journal:  Science       Date:  1993-06-18       Impact factor: 47.728

10.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

View more
  10 in total

1.  The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab.

Authors:  J-P Jais; C Haioun; T J Molina; D S Rickman; A de Reynies; F Berger; C Gisselbrecht; J Brière; F Reyes; P Gaulard; P Feugier; E Labouyrie; H Tilly; C Bastard; B Coiffier; G Salles; K Leroy
Journal:  Leukemia       Date:  2008-07-10       Impact factor: 11.528

2.  Reprogramming of the HepG2 genome by long interspersed nuclear element-1.

Authors:  Pasano Bojang; Ruth A Roberts; Mark J Anderton; Kenneth S Ramos
Journal:  Mol Oncol       Date:  2013-04-17       Impact factor: 6.603

3.  The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.

Authors:  Qihan Chen; Xiao Xiao; Aaron Wolfe; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2016-04-08       Impact factor: 5.469

4.  Innate immune responses in primary HIV-1 infection.

Authors:  Persephone Borrow; Nina Bhardwaj
Journal:  Curr Opin HIV AIDS       Date:  2008-01       Impact factor: 4.283

Review 5.  Mighty Piwis defend the germline against genome intruders.

Authors:  Kathryn A O'Donnell; Jef D Boeke
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

6.  Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription.

Authors:  Kate L Jones; Secondo Sonza; Johnson Mak
Journal:  Nucleic Acids Res       Date:  2008-01-23       Impact factor: 16.971

7.  Host APOBEC3G protein inhibits HCV replication through direct binding at NS3.

Authors:  Yan-Ping Zhu; Zong-Gen Peng; Zhou-Yi Wu; Jian-Rui Li; Meng-Hao Huang; Shu-Yi Si; Jian-Dong Jiang
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 8.  Single-Cell Sequencing Facilitates Elucidation of HIV Immunopathogenesis: A Review of Current Literature.

Authors:  Silvere D Zaongo; Vijay Harypursat; Yaokai Chen
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

9.  Complex codon usage pattern and compositional features of retroviruses.

Authors:  Sourav RoyChoudhury; Debaprasad Mukherjee
Journal:  Comput Math Methods Med       Date:  2013-10-31       Impact factor: 2.238

10.  Compare mDCs and pDCs between two distinct patients groups in acute HIV-1 infection.

Authors:  Yanmei Jiao; Xin Sun; Xiaojie Huang; Wei Li; Tong Zhang; Hao Wu
Journal:  AIDS Res Ther       Date:  2014-07-31       Impact factor: 2.250

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.